carbamates has been researched along with Tuberculosis, Drug-Resistant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sangana, R | 1 |
| Gu, H | 1 |
| Chun, DY | 1 |
| Einolf, HJ | 1 |
| Baranyai, Z | 1 |
| Krátký, M | 1 |
| Vinšová, J | 1 |
| Szabó, N | 1 |
| Senoner, Z | 1 |
| Horváti, K | 1 |
| Stolaříková, J | 1 |
| Dávid, S | 1 |
| Bősze, S | 1 |
| White, EL | 1 |
| Suling, WJ | 1 |
| Ross, LJ | 1 |
| Seitz, LE | 1 |
| Reynolds, RC | 1 |
3 other studies available for carbamates and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches.
Topics: Antitubercular Agents; Area Under Curve; Carbamates; Clofazimine; Cytochrome P-450 Enzyme Inhibitors | 2018 |
Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Topics: Anti-Bacterial Agents; Carbamates; Cell Line; Dose-Response Relationship, Drug; Esters; Humans; Micr | 2015 |
2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ.
Topics: Animals; Antitubercular Agents; Azepines; Bacterial Proteins; Bone Marrow Cells; Carbamates; Chloroc | 2002 |